glutathione pathway to triple negative cancer GPX4 in triple-negative breast cancer: A key regulator of ferroptosis and therapeutic target Glutathione depletion and dihydroorotate dehydrogenase
Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Glutathione Dependent Pathways in Cancer Cells Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



